Compugen (CGEN) Misses Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. ABBV
2. SLGN
3. EYPT
4. CRWV
5. MANE
6. LTFH:IN
7. PNB:IN
8. LTM:IN
9. VEON
10. GP

Go back to Compugen (CGEN) Misses Q1 EPS by 1c

Compugen Reports First Quarter 2026 Results

May 18, 2026 7:00 AM EDT

COM701 MAIA-ovarian trial actively enrolling patients across all clinical sites in the U.S., Israel, and France; interim analysis on track by Q1 2027Partner AstraZeneca is advancing rilvegostomig across 11 ongoing Phase 3 trials and presented clinical and pre-clinical rilvegostomig data at AACR 2026, including late-breaking Phase 2 data in HER2-positive gastric cancer (DESTINY-Gastric03), with new data to be released at ASCO 2026Gilead-partnered GS-0321 Phase 1 trial continues to progress as plannedSolid... More